Literature DB >> 17202296

Towards systems biology of human pulmonary fibrosis.

Sean M Studer1, Naftali Kaminski.   

Abstract

The integrated effect of multiple pathways, molecules, genetic polymorphisms, environmental stimuli, and possible infection determines the lung phenotype in idiopathic pulmonary fibrosis (IPF), a chronic progressive and often lethal lung disease. Systems biology approaches aim to provide a systemwide view of biological process using computational tools and high-throughput technologies. Although much of the analysis of genome-level transcriptional high-resolution profiles of IPF was reductionist, usually focusing on a single factor in the disease process, there are some studies that implement systems approaches. We discuss these analyses and provide examples of the global analysis of IPF, hypersensitivity pneumonitis, and nonspecific interstitial pneumonia. Detailed quantitative phenotyping and correlation with microarray results as well as high-throughput genotyping should provide us with the datasets to implement systems biology approaches in fibrosis research. Interdisciplinary teams and training of junior investigators in the vocabulary of systems biology should allow us to use these datasets integratively and generate a global model of human pulmonary fibrosis.

Entities:  

Mesh:

Year:  2007        PMID: 17202296      PMCID: PMC2647618          DOI: 10.1513/pats.200607-139JG

Source DB:  PubMed          Journal:  Proc Am Thorac Soc        ISSN: 1546-3222


  38 in total

1.  Global analysis of gene expression in pulmonary fibrosis reveals distinct programs regulating lung inflammation and fibrosis.

Authors:  N Kaminski; J D Allard; J F Pittet; F Zuo; M J Griffiths; D Morris; X Huang; D Sheppard; R A Heller
Journal:  Proc Natl Acad Sci U S A       Date:  2000-02-15       Impact factor: 11.205

2.  Overexpression of matrix metalloproteinase-7 in pulmonary fibrosis.

Authors:  Gregory P Cosgrove; Marvin I Schwarz; Mark W Geraci; Kevin K Brown; G Scott Worthen
Journal:  Chest       Date:  2002-03       Impact factor: 9.410

Review 3.  Microarray analysis of idiopathic pulmonary fibrosis.

Authors:  Naftali Kaminski
Journal:  Am J Respir Cell Mol Biol       Date:  2003-09       Impact factor: 6.914

Review 4.  Surfactant protein D and KL-6 as serologic indicators of Pneumocystis carinii pneumonia in a child with acute lymphoblastic leukemia.

Authors:  T Takahashi; Y Ebihara; A Manabe; K Tsuji; T Nakamura; T Nakahata; A Iwamoto
Journal:  J Med       Date:  2001

Review 5.  Transforming growth factor beta: a central modulator of pulmonary and airway inflammation and fibrosis.

Authors:  Dean Sheppard
Journal:  Proc Am Thorac Soc       Date:  2006-07

6.  Molecular monitoring of bleomycin-induced pulmonary fibrosis by cDNA microarray-based gene expression profiling.

Authors:  S Katsuma; K Nishi; K Tanigawara; H Ikawa; S Shiojima; K Takagaki; Y Kaminishi; Y Suzuki; A Hirasawa; T Ohgi; J Yano; Y Murakami; G Tsujimoto
Journal:  Biochem Biophys Res Commun       Date:  2001-11-09       Impact factor: 3.575

7.  Gene expression analysis reveals matrilysin as a key regulator of pulmonary fibrosis in mice and humans.

Authors:  Fengrong Zuo; Naftali Kaminski; Elsie Eugui; John Allard; Zohar Yakhini; Amir Ben-Dor; Lance Lollini; David Morris; Yong Kim; Barbara DeLustro; Dean Sheppard; Annie Pardo; Moises Selman; Renu A Heller
Journal:  Proc Natl Acad Sci U S A       Date:  2002-04-30       Impact factor: 11.205

8.  caGrid: design and implementation of the core architecture of the cancer biomedical informatics grid.

Authors:  Joel Saltz; Scott Oster; Shannon Hastings; Stephen Langella; Tahsin Kurc; William Sanchez; Manav Kher; Arumani Manisundaram; Krishnakant Shanbhag; Peter Covitz
Journal:  Bioinformatics       Date:  2006-06-09       Impact factor: 6.937

Review 9.  Re-evaluation of fibrogenic cytokines in lung fibrosis.

Authors:  Margaret Kelly; Martin Kolb; Phillipe Bonniaud; Jack Gauldie
Journal:  Curr Pharm Des       Date:  2003       Impact factor: 3.116

10.  Bleomycin hydrolase and a genetic locus within the MHC affect risk for pulmonary fibrosis in mice.

Authors:  Christina K Haston; Min Wang; Robert E Dejournett; Xinhui Zhou; Dan Ni; Xiangjun Gu; Terri M King; Michael M Weil; Robert A Newman; Christopher I Amos; Elizabeth L Travis
Journal:  Hum Mol Genet       Date:  2002-08-01       Impact factor: 6.150

View more
  18 in total

1.  Genomics and proteomics of lung disease: conference summary.

Authors:  J Usha Raj; Constantin Aliferis; Richard M Caprioli; Allen W Cowley; Peter F Davies; Mark W Duncan; David J Erle; Serpil C Erzurum; Patricia W Finn; Harry Ischiropoulos; Naftali Kaminski; Steven R Kleeberger; George D Leikauf; James E Loyd; Thomas R Martin; Sadis Matalon; Jason H Moore; John Quackenbush; Tara Sabo-Attwood; Steve D Shapiro; Jan E Schnitzer; David A Schwartz; Lisa M Schwiebert; Dean Sheppard; Lorraine B Ware; Scott T Weiss; Jeff A Whitsett; Mark M Wurfel; Michael A Matthay
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2007-04-27       Impact factor: 5.464

Review 2.  Evolving genomic approaches to idiopathic pulmonary fibrosis: moving beyond genes.

Authors:  Daniel J Kass; Naftali Kaminski
Journal:  Clin Transl Sci       Date:  2011-10       Impact factor: 4.689

3.  Fibrosis of two: Epithelial cell-fibroblast interactions in pulmonary fibrosis.

Authors:  Norihiko Sakai; Andrew M Tager
Journal:  Biochim Biophys Acta       Date:  2013-03-14

Review 4.  Interstitial lung diseases in children.

Authors:  Annick Clement; Nadia Nathan; Ralph Epaud; Brigitte Fauroux; Harriet Corvol
Journal:  Orphanet J Rare Dis       Date:  2010-08-20       Impact factor: 4.123

Review 5.  Application of OMICS technologies in occupational and environmental health research; current status and projections.

Authors:  J Vlaanderen; L E Moore; M T Smith; Q Lan; L Zhang; C F Skibola; N Rothman; R Vermeulen
Journal:  Occup Environ Med       Date:  2009-11-20       Impact factor: 4.402

6.  Intercellular interactomics of human brain endothelial cells and th17 lymphocytes: a novel strategy for identifying therapeutic targets of CNS inflammation.

Authors:  Arsalan S Haqqani; Danica B Stanimirovic
Journal:  Cardiovasc Psychiatry Neurol       Date:  2011-06-13

7.  Twist: a regulator of epithelial-mesenchymal transition in lung fibrosis.

Authors:  Veronika Pozharskaya; Edilson Torres-González; Mauricio Rojas; Anthony Gal; Minal Amin; Sheila Dollard; Jesse Roman; Arlene A Stecenko; Ana L Mora
Journal:  PLoS One       Date:  2009-10-23       Impact factor: 3.240

8.  Molecular mechanisms of nanosized titanium dioxide-induced pulmonary injury in mice.

Authors:  Bing Li; Yuguan Ze; Qingqing Sun; Ting Zhang; Xuezi Sang; Yaling Cui; Xiaochun Wang; Suxin Gui; Danlin Tan; Min Zhu; Xiaoyang Zhao; Lei Sheng; Ling Wang; Fashui Hong; Meng Tang
Journal:  PLoS One       Date:  2013-02-07       Impact factor: 3.240

9.  Diagnostic approach to interstitial pneumonias in a single centre: report on 88 cases.

Authors:  Dirk Theegarten; Heike Maria Müller; Francesco Bonella; Jeremias Wohlschlaeger; Ulrich Costabel
Journal:  Diagn Pathol       Date:  2012-11-26       Impact factor: 2.644

10.  Idiopathic pulmonary fibrosis: the need for early diagnosis.

Authors:  Gaetano Cicchitto; Claudio M Sanguinetti
Journal:  Multidiscip Respir Med       Date:  2013-08-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.